Related Experiment Video
Updated: Aug 13, 2026
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT-PCR
Etienne Caron1, Nathalie Rioux, Olivier Nicolas
1Department of Pharmacology and Toxicology, Shire-Biochem Inc., Laval, Quebec, Canada.
Abstract:
The administration of xenobiotics may significantly alter the expression of cytochromes P450 (CYPs), thereby leading to potentially toxic cellular, physiologic, and pharmacologic responses. Indeed, an important task in the development of new therapeutic entities is to evaluate efficiently and quantitatively their potential effects on the expression level of different CYPs. In this report, reverse transcriptase polymerase chain reaction (RT-PCR) was used to measure basal and induced mRNA of a wide range of rat CYP isoforms. Rats (n=3 per treatment) were treated with five prototype inducers of CYP isoforms or with vehicle only. RT and PCR efficiencies were determined using appropriate RNA and DNA standards. Messenger RNA was quantified by PicoGreen standard curves and normalized to cyclophilin. Quantitative RT-PCR was used successfully to demonstrate that CYP isoforms were induced at the mRNA level following drug administration. Notably, phenobarbital resulted in significant induction of CYP2B1, CYP2B2, CYP2C6, CYP2C13, CYP2E1, CYP3A1, and CYP3A2. 3-Methylcholanthrene induced CYP1A1, CYP1A2, and CYP1B1. CYP2C11 expression was highly variable and suppressed by pyridine, whereas the expression of CYP2E1 was suppressed by dexamethasone. We demonstrated that quantitative RT-PCR can be used to evaluate efficiently the effect of compounds on the expression of a wide range of CYP isoforms. The technique is advantageous over others in that it is very sensitive, efficient and applicable to highly homologous CYP isoforms.
Insights
Quantitative reverse transcriptase polymerase chain reaction (RT-PCR) effectively measures drug effects on cytochrome P450 (CYP) gene expression. This sensitive method aids in evaluating potential toxicities during new drug development.
Area of Science:
- Pharmacology
- Molecular Biology
- Toxicology
Background:
- Xenobiotics can alter cytochrome P450 (CYP) expression, potentially causing adverse cellular, physiological, and pharmacological effects.
- Efficiently evaluating the impact of new therapeutic entities on CYP expression is crucial in drug development.
Purpose of the Study:
- To assess the utility of quantitative reverse transcriptase polymerase chain reaction (RT-PCR) for measuring basal and induced messenger RNA (mRNA) levels of various rat CYP isoforms.
- To determine the effects of prototype CYP inducers and suppressors on specific CYP isoform mRNA expression.
Main Methods:
- Quantitative RT-PCR was employed to measure mRNA levels of multiple rat CYP isoforms.
- Rats were treated with five prototype inducers or vehicle; mRNA was quantified using PicoGreen standard curves and normalized to cyclophilin.
- RT and PCR efficiencies were validated using RNA and DNA standards.
Main Results:
- Quantitative RT-PCR successfully demonstrated drug-induced changes in CYP isoform mRNA expression.
- Phenobarbital significantly induced multiple CYP isoforms (e.g., CYP2B1, CYP2C6, CYP3A1).
- 3-Methylcholanthrene induced CYP1A1, CYP1A2, and CYP1B1; pyridine suppressed CYP2C11; dexamethasone suppressed CYP2E1.
Conclusions:
- Quantitative RT-PCR is a sensitive, efficient, and applicable method for evaluating the effects of compounds on a broad range of CYP isoforms.
- This technique provides a valuable tool for assessing potential drug-drug interactions and toxicological profiles during pharmaceutical development.
